ecancermedicalscience

Research

Clustering-based identification of immune-related gene signatures in hepatocellular carcinoma

17 Oct 2025
Jyoti Brahmaiah, Usha Adiga, Alfred J Augustine, Sampara Vasishta

Background: Hepatocellular carcinoma (HCC) is a complex malignancy influenced by genetic, epigenetic and immune-related factors. The tumour immune microenvironment plays a critical role in HCC progression and response to immunotherapy. Identifying key immune-related gene signatures through clustering techniques can provide insights into tumour biology and therapeutic targets.

Methods: We employed K-means, Markov Clustering Algorithm (MCL) and density-based spatial clustering of applications with noise (DBSCAN) to analyse immune-related genes in HCC. Functional enrichment analysis was conducted using Gene Ontology (GO) biological process, cellular component and molecular function categories, along with pathway analysis from Kyoto encyclopedia of genes and genomes (KEGG) and Reactome databases. Additionally, protein–protein interaction (PPI) hub analysis and microRNAs (miRNA) target predictions were integrated to understand the regulatory networks.

Results: K-means clustering segregated immune genes into three clusters, with major histocompatibility complex (MHC) class II genes forming a distinct cluster. MCL and DBSCAN identified a more unified immune cluster incorporating both MHC class I and II molecules, suggesting their coordinated role in antigen presentation. GO analysis revealed enrichment in antigen processing and presentation pathways, immunoglobulin-mediated responses and glutamate receptor signaling. KEGG pathway analysis highlighted associations with autoimmune diseases and viral infections. PPI hub analysis identified CD4, CD74 and HLA-DQA1 as central nodes, while miRNA analysis suggested regulatory interactions affecting immune gene expression.

Conclusion: Our clustering analysis highlights distinct immune-related gene signatures in HCC, emphasising the role of antigen presentation and immune modulation in tumour progression. The findings provide a foundation for further investigation into immunotherapeutic strategies targeting key immune pathways in HCC.

Related Articles

M T Maria Tereza Nieto-Coronel, Daniela Shveid Gerson, Gian Karla Urey Cuellar, Navia-Bueno Ma Pilar, Maribel Marmol Casas
Ashutosh Mishra, Amit Kumar, Ajay Gogia, Chinmay Bagla, Gajendra Pandit, Jyoti Sharma, Jyoutishman Saikia, Rohan Kapoor, D N Sharma, Atul Batra, Surendra Saini, Supriya Mallick, Nishkarsh Gupta, Brajesh Ratre, Ruchi Rathore, Sandeep Mathur, Sunil Kumar, Suryanarayana Deo
Moushumi Suryavanshi, Prashant Mehta, Manoj Kumar, Saphalta Bhagmar, Vidit Kapoor, Dushyant Kumar, Sweta Mishra, Bhawna Chauhan
Maria Lucila González Donna, Eliza Ramirez Cabrera, Andrea Magali del Valle Ochelli, Lucia Ayala Albertini, Lucas Coradini, Verónica Alejandra Livieres Alayón, Iván Garrigoza Garcete, Cinthia Gauna Colas, Maria Luisa Cabañas León, Jabibi Noguera, Gladys Estigarribia, Alejandro Frydman, Carlos Palmes, Santiago Leguizamon, Matias Rodrigo Chacon, Federico Waisberg